Designing Dual Compartment HIV Prevention Products: Women's Sensory Perceptions and Experiences of Suppositories for Rectal and Vaginal Use.
dual compartment products
perceptibility
rectal HIV prevention
sensory experiences
suppositories
vaginal HIV prevention
Journal
AIDS research and human retroviruses
ISSN: 1931-8405
Titre abrégé: AIDS Res Hum Retroviruses
Pays: United States
ID NLM: 8709376
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
pubmed:
22
9
2021
medline:
19
7
2022
entrez:
21
9
2021
Statut:
ppublish
Résumé
Dual compartment suppositories are being developed to prevent HIV and other sexually transmitted infections. Such products, for use in the rectum, the vagina, or both, could have a significant public health impact by decreasing global incidence of these diseases. In this study, 16 women each used two rheologically distinct suppositories in their vagina and rectum. User Sensory Perception and Experience (USPE) scales assessed sensory experiences during sexual activity to understand whether, and how, women perceive formulation properties in the vagina and rectum. Qualitative data from individual in-depth interviews captured women's descriptions and comparisons of the experiences. Significant differences and large Cohen's
Identifiants
pubmed: 34544269
doi: 10.1089/AID.2021.0038
pmc: PMC9297320
doi:
Substances chimiques
Suppositories
0
Banques de données
ClinicalTrials.gov
['NCT02744261']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
601-610Références
AIDS Res Hum Retroviruses. 2014 Jan;30(1):78-91
pubmed: 24180360
AIDS Res Hum Retroviruses. 2020 Dec;36(12):1059-1070
pubmed: 32988214
J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):393-400
pubmed: 23535293
AIDS. 2008 Dec;22 Suppl 4:S27-40
pubmed: 19033753
Int J Epidemiol. 2010 Aug;39(4):1048-63
pubmed: 20406794
Clin Pharmacokinet. 1982 Jul-Aug;7(4):285-311
pubmed: 6126289
Pharm Dev Technol. 2018 Mar;23(3):311-314
pubmed: 28592183
J Control Release. 2005 Mar 21;103(2):301-13
pubmed: 15763615
Qual Health Res. 2017 Jul;27(8):1236-1248
pubmed: 28682740
BMC Womens Health. 2018 Oct 20;18(1):170
pubmed: 30342510
AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1022-1030
pubmed: 26942455
AIDS Educ Prev. 2016 Feb;28(1):1-10
pubmed: 26829253
J Sex Res. 2016 Jul-Aug;53(6):633-41
pubmed: 26132717
Antiviral Res. 2015 Aug;120:153-64
pubmed: 26093158
AIDS Patient Care STDS. 2003 Jan;17(1):17-32
pubmed: 12614517
AIDS Patient Care STDS. 2003 Aug;17(8):377-99
pubmed: 13678540
AIDS Behav. 2013 Mar;17(3):1002-15
pubmed: 23114512
Am J Health Behav. 2003 May-Jun;27(3):228-34
pubmed: 12751619
AIDS Behav. 2014 Sep;18(9):1726-33
pubmed: 24719200
J Control Release. 2014 Nov 28;194:278-94
pubmed: 25229988
AIDS Res Hum Retroviruses. 2017 May;33(5):440-447
pubmed: 27824253
AIDS Behav. 2011 Apr;15 Suppl 1:S66-71
pubmed: 21331798
Drug Deliv Transl Res. 2017 Oct;7(5):761-770
pubmed: 28653286
J Sex Res. 2010 Mar;47(2):123-36
pubmed: 20358456
Ther Deliv. 2017 Aug;8(9):805-817
pubmed: 28825395
Clin Pharmacokinet. 1991 Aug;21(2):110-28
pubmed: 1884566
AIDS Educ Prev. 2008 Apr;20(2):148-59
pubmed: 18433320
Lancet Infect Dis. 2005 Dec;5(12):786-94
pubmed: 16310150
Sex Transm Dis. 1998 Jul;25(6):296-302
pubmed: 9662763
J Antimicrob Chemother. 2012 Sep;67(9):2139-42
pubmed: 22581908
AIDS Care. 2002 Dec;14(6):789-800
pubmed: 12511212
Antiviral Res. 2013 Mar;97(3):280-4
pubmed: 23276592